Convenio Suministro Medicamentos para Pabellón
Suministrar por un periodo de 18 meses medicamentos utilizados en la Unidad de Pabellón para la atención oportuna, eficiente y eficaz de los pacientes tratados en el HTC
13 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058037-47-SE23 | 26-01-2023 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-7-SE23 | 12-01-2023 | Laboratorio Sanderson S.A. | $93.058 |
| 1058037-297-SE22 | 02-12-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-263-SE22 | 20-10-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-253-SE22 | 06-10-2022 | Laboratorio Biosano S.A. | $39.270 |
| 1058037-241-SE22 | 27-09-2022 | Laboratorio Sanderson S.A. | $87.406 |
| 1058037-221-SE22 | 08-09-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-182-SE22 | 01-08-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-177-SE22 | 01-08-2022 | Laboratorio Biosano S.A. | $39.270 |
| 1058037-175-SE22 | 01-08-2022 | Farmaceutica Insuval S.A. | $104.720 |
| 1058037-125-SE22 | 06-06-2022 | Farmaceutica Insuval S.A. | $130.900 |
| 1058037-123-SE22 | 06-06-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-113-SE22 | 19-05-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-95-SE22 | 02-05-2022 | Farmaceutica Insuval S.A. | $209.440 |
| 1058037-94-SE22 | 02-05-2022 | Laboratorio Sanderson S.A. | $214.200 |
| 1058037-86-SE22 | 25-04-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-75-SE22 | 05-04-2022 | Laboratorio Sanderson S.A. | $107.100 |
| 1058037-66-SE22 | 29-03-2022 | Farmaceutica Insuval S.A. | $209.440 |
| 1058037-53-SE22 | 15-03-2022 | Gador Limitada | $271.320 |
| 1058037-51-SE22 | 15-03-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-30-SE22 | 18-02-2022 | Laboratorio Sanderson S.A. | $107.100 |
| 1058037-17-SE22 | 01-02-2022 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-12-SE22 | 24-01-2022 | Farmaceutica Insuval S.A. | $209.440 |
| 1058037-413-SE21 | 29-12-2021 | Laboratorio Sanderson S.A. | $107.100 |
| 1058037-412-SE21 | 21-12-2021 | Farmaceutica Insuval S.A. | $130.900 |
| 1058037-402-SE21 | 10-12-2021 | Fresenius Kabi Chile Limitada | $642.600 |
| 1058037-377-SE21 | 15-11-2021 | Farmaceutica Insuval S.A. | $261.800 |
| 1058037-358-SE21 | 18-10-2021 | Farmaceutica Insuval S.A. | $183.260 |
| 1058037-323-SE21 | 27-08-2021 | Laboratorio Sanderson S.A. | $55.038 |
| 1058037-324-SE21 | 27-08-2021 | Farmaceutica Insuval S.A. | $130.900 |
Fuente original:ficha mercadopublico.cl
